As of 2025-05-18, the Fair Value of Stoke Therapeutics Inc (STOK) is -8.15 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.76 USD, the upside of Stoke Therapeutics Inc is -183.49%.
With the market price of 9.76 USD and our fair value calculation, Stoke Therapeutics Inc (STOK) is not a good investment. Investing in STOK stocks now will result in a potential loss of 183.49%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -52.24 | -85.81 | -101.07 | -104.70 | -88.98 | -86.56 |
| YoY growth | -61.58% | -64.26% | -17.78% | -3.59% | 15.01% | -26.44% |
| Market Cap (mil) | 532.90 |
| P/E | |
| Forward P/E |
| EPS | -1.63 |
| Avg earnings growth rate | -26.44% |
| TTM earnings | -88.98 |